Dopamine agonist therapy in prolactinomas: when can treatment be discontinued?
Klibanski
Anne
A
D018491:Dopamine Agonists / Q000627:therapeutic use*; D006801:Humans; D009364:Neoplasm Recurrence, Local / Q000209:etiology / Q000473:pathology; D018365:Neoplasm, Residual; D010911:Pituitary Neoplasms / Q000188:drug therapy* / Q000473:pathology; D015175:Prolactinoma / Q000188:drug therapy* / Q000473:pathology; D013997:Time Factors; D047368:Tumor Burden; D028761:Withholding Treatment
D018491:Dopamine Agonists